Sort
40,608 grants matching “prostate cancer”
Center for Interventional Oncology
$711,768Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
NATIONAL COMPREHENSIVE CANCER CONTROL PROGRAM, PROSTATE CANCER AND COLORECTAL
$711,347Stevenson J Kuartei · Republic Of Palau Ministry Of Health · U58 · FY2010 · DP
UCLA Imaging Resource for Mouse Cancer Models
$711,291University Of California Los Angeles · R24 · FY2003 · CA
THERAPEUTIC TARGETING OF RECURRENT CASTRATE RESISTANT PROSTATE CANCER BY ACK1 TYROSINE KINASE INHIBITOR (R)-9B.
$711,109Washington University, The · · FY2021 · Defense Health Agency
Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer
$710,980Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer
$710,980Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Magneto-Nano Protein Chip and Multiplex Sorter for Monitoring Tumor Markers
$710,978Shan X. Wang · Stanford University · U54 · FY2009 · CA
TARGETING THE ADIPOCYTE-TUMOR CELL INTERACTION IN PROSTATE CANCER TREATMENT
$710,596Sanford Burnham Prebys Medical Discovery Institute · · FY2013 · Department of Defense
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE
$710,555Burnham Institute For Medical Research · R37 · FY2001 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$710,486Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
IMMUNOTHERAPY OF PROSTATE CANCER WITH GENETICALLY ENHANCES TUMOR-SPECIFIC T-CELL PRECURSORS
$710,378Sloan-Kettering Institute For Cancer Research · · FY2009 · Department of the Army
Microbes and Human Malignancies
$710,295James J Goedert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Quantifying patient-provider communication using machine learning to assess its impact on metastatic cancer patients' outcomes
$710,264Samah Jamal Fodeh Jarad · Yale University · R01 · FY2024 · CA
Immersive Virtual Environment Testing Area
$710,195Susan Persky · National Human Genome Research Institute · ZID · FY2014 · HG
EPSIN: A NOVEL REGULATOR IN PROSTATE CANCER PROGRESSION AND METASTASIS
$709,960Oklahoma Medical Research Foundation · · FY2011 · Department of Defense
MOLECULAR CROSS-TALK: BONE METASTATIC PROSTATE CANCER AND NOCICEPTIVE NEURONS
$709,942Wake Forest University Health Sciences · · FY2017 · Department of the Army
Exploring PSMA Biology in Tumor neovasculature
$709,876Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$709,818Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2014 · CA
DEVELOPMENT OF ASSAYS FOR DETECTING SIGNIFICANT PROSTATE CANCER BASED ON MOLECULAR ALTERATIONS ASSOCIATED WITH CANCER IN NON-NEOPLASTIC PROSTATE TISS
$709,650Mayo Clinic · · FY2011 · Department of Defense
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
$709,605Thomas E Seay · St. Joseph'S Hospital · U10 · FY2009 · CA
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$709,538Margaret M Whalen · Tennessee State University · U54 · FY2023 · CA
SPORE in Lung Cancer
$709,265Stephen B Baylin · Johns Hopkins University · P50 · FY2009 · CA
RCT of an Online Multimedia Program to Boost Coping & Function for Pca Survivors
$708,941Suzanne M Miller · Fox Chase Cancer Center · R01 · FY2012 · CA
RAPIDCAP, A NOVEL GEM MODEL TO FIGHT TREATMENT-RESISTANT METASTATIC PROSTATE CANCER
$708,750Cold Spring Harbor Laboratory · · FY2014 · Department of Defense
CONSTITUTIVE TBK1 AND IKKI ACTIVATION DRIVES METASTATIC PROSTATE CANCER DEVELOPMENT
$708,750Scripps Research Institute, The · · FY2015 · Department of Defense